Abstract:INTRODUCTION:Previous observational studies have found that the susceptibility of coronavirus disease 2019 (COVID-19) and the risk of severe COVID-19 are not increased in patients with celiac disease (CeD). However, the findings of observational studies are prone to bias due to reverse causation and confounding factors, especially in the case of a newly emerged disease. In this study, we aimed to further clarify the underlying relationship by both observational and Mendelian randomization (MR) analysis.METHODS… Show more
“…930 articles were further excluded after considering the title and abstract, generating 68 papers for satisfactory article review for plausible consideration in this analysis. Eventually, 11 articles consisting of 44,378 celiac patients were incorporated into this meta‐analysis based on exhaustive evaluation and inclusion criteria 8,14–23 . The baseline characteristics of the incorporated studies are summarised in Table 1.…”
Section: Resultsmentioning
confidence: 99%
“…Eventually, 11 articles consisting of 44,378 celiac patients were incorporated into this meta-analysis based on exhaustive evaluation and inclusion criteria. 8,[14][15][16][17][18][19][20][21][22][23] The baseline characteristics of the incorporated studies are summarised in Table 1. Four of these included studies were from Italy, followed by the USA with two reports and one from Iran, Sweden, and the United Kingdom.…”
Section: Characteristics Of the Included Studiesmentioning
There is a scarcity of scientific evidence addressing the outcomes of COVID‐19 in celiac disease (CD) patients. This systematic review and meta‐analysis aimed to evaluate the correlation between pre‐existing CD and COVID‐19. A rigorous literature search was conducted using multiple databases. All eligible observational studies were included from around the globe. The random effect model calculated the pooled prevalence and associated 95% confidence intervals (CI). Mantel‐Haenszel odds ratios were produced to report the overall effect size using random effect models for severity and mortality outcomes. Funnel plots, Egger regression tests, and Begg‐Mazumdar's rank correlation test were used to appraise publication bias. Data from 11 articles consisting of 44,378 CD patients were obtained. Overall pooled random‐effects estimate of SARS‐CoV‐2 infection in CD patients was 4.25% (95% CI, I2 = 98%). Our findings also indicated that pre‐existing CD was not associated with an increased risk of hospitalisation with COVID‐19 illness (OR = 1.04, 95% CI 0.87–1.24, I2 = 0%) and mortality due to illness (OR = 0.92, 95% CI 0.56–1.5, I2 = 45%) compared with patients without pre‐existing CD. No significant publication bias was evident in the meta‐analysis. The preliminary data from our analysis suggest that SARS‐CoV‐2 infection in patients with pre‐existing CD is not associated with an increased risk of hospitalisation or mortality. Additional studies are required to overcome the restrictions of the limited data available at present.
“…930 articles were further excluded after considering the title and abstract, generating 68 papers for satisfactory article review for plausible consideration in this analysis. Eventually, 11 articles consisting of 44,378 celiac patients were incorporated into this meta‐analysis based on exhaustive evaluation and inclusion criteria 8,14–23 . The baseline characteristics of the incorporated studies are summarised in Table 1.…”
Section: Resultsmentioning
confidence: 99%
“…Eventually, 11 articles consisting of 44,378 celiac patients were incorporated into this meta-analysis based on exhaustive evaluation and inclusion criteria. 8,[14][15][16][17][18][19][20][21][22][23] The baseline characteristics of the incorporated studies are summarised in Table 1. Four of these included studies were from Italy, followed by the USA with two reports and one from Iran, Sweden, and the United Kingdom.…”
Section: Characteristics Of the Included Studiesmentioning
There is a scarcity of scientific evidence addressing the outcomes of COVID‐19 in celiac disease (CD) patients. This systematic review and meta‐analysis aimed to evaluate the correlation between pre‐existing CD and COVID‐19. A rigorous literature search was conducted using multiple databases. All eligible observational studies were included from around the globe. The random effect model calculated the pooled prevalence and associated 95% confidence intervals (CI). Mantel‐Haenszel odds ratios were produced to report the overall effect size using random effect models for severity and mortality outcomes. Funnel plots, Egger regression tests, and Begg‐Mazumdar's rank correlation test were used to appraise publication bias. Data from 11 articles consisting of 44,378 CD patients were obtained. Overall pooled random‐effects estimate of SARS‐CoV‐2 infection in CD patients was 4.25% (95% CI, I2 = 98%). Our findings also indicated that pre‐existing CD was not associated with an increased risk of hospitalisation with COVID‐19 illness (OR = 1.04, 95% CI 0.87–1.24, I2 = 0%) and mortality due to illness (OR = 0.92, 95% CI 0.56–1.5, I2 = 45%) compared with patients without pre‐existing CD. No significant publication bias was evident in the meta‐analysis. The preliminary data from our analysis suggest that SARS‐CoV‐2 infection in patients with pre‐existing CD is not associated with an increased risk of hospitalisation or mortality. Additional studies are required to overcome the restrictions of the limited data available at present.
“…Lastly, observational studies examined the risk of severe COVID-19 and mortality in patients with celiac disease. These studies were not specific to pediatrics, but overall, they did not find an increased risk of severe COVID-19 in individuals with celiac disease and compliant with a gluten-free diet [27 ▪ ,29].…”
Section: Covid-19 and Celiac Diseasementioning
confidence: 92%
“…During the COVID-19 pandemic, studies explored SARS-CoV-2 as a potential trigger for different autoimmune conditions. Although type 1 diabetes became more frequently diagnosed [25 ▪ ], studies failed to demonstrate an increased incidence of celiac disease during the pandemic [26,27 ▪ ]. It is unclear if this was the result of the increased hygienic measures leading to decreased exposure to SARS-COV-2 and other viruses typically associated with an increased risk of developing celiac disease such as enteroviruses, adenoviruses, and rotaviruses.…”
Purpose of reviewThis is an overview of the effects of COVID-19 in the gastrointestinal tract in children, and current evidence of the impact of COVID-19 in pediatric patients with chronic gastrointestinal conditions, including inflammatory bowel disease (IBD), chronic liver disease, and disorders of the gut-brain interaction.
Recent findingsChildren with COVID-19 have a milder course and more favorable outcomes than adults, even in those with immunosuppression due to IBD or liver transplantation. Children with chronic gastrointestinal conditions do not have worse clinical outcomes than healthy children and infection itself has not been linked to an increased incidence of conditions such as IBD and celiac disease, but results regarding postinfectious irritable bowel syndrome are mixed.
“…83 Also adult studies have unequivocally shown a similar incidence of COVID-19 in CeD as in the general journals.sagepub.com/home/tag TherapeuTic advances in Gastroenterology population. [84][85][86] Likewise, a large US study (TriNETX) found no significantly increased risk of hospital admission, critical care, or death from COVID-19. 87…”
Section: Celiac Disease and Risk Of Covid-19mentioning
During the past 3 years, the coronavirus disease 2019 (COVID-19) pandemic has had a great impact on people all over the world. However, it has become evident that disease manifestations and severity differ across age groups. Most children have a milder disease course than adults but possibly more pronounced gastrointestinal (GI) symptoms. Given the child’s developing immune system, the impact of COVID-19 on disease development may differ compared to adults. This study reviews the potential bi-directional relationship between COVID-19 and GI diseases in children, focusing on common pediatric conditions such as functional GI disorders (FGID), celiac disease (CeD), and inflammatory bowel disease (IBD). Children with GI diseases, in general, and CeD and IBD, in particular, do not seem to have an increased risk of severe COVID-19, including risks of hospitalization, critical care need, and death. While infections are considered candidate environmental factors in both CeD and IBD pathogenesis, and specific infectious agents are known triggers for FGID, there is still not sufficient evidence to implicate COVID-19 in the development of either of these diseases. However, given the scarcity of data and the possible latency period between environmental triggers and disease development, future investigations in this field are warranted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.